Press Releases & Clinical Resources
PRESS RELEASES
Feburary 15, 2024
FDA acceptance of double blind, randomized, placebo, controlled Clinical Trial for Long Covid
Click to View
April 10, 2024
PeploBio and IncellDX partner to launch The First Long Covid test in the UK and EU
Click to View
CLINICAL RESOURCES
CLINICAL STUDY
Long COVID Diagnostic with Differentiation from Chronic Lyme Disease using Machine Learning and Cytokine Hub
CLINICAL STUDY
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19(PASC) up to 15 Months Post Infection
NIH NATIONAL LIBRARY
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
CLINICAL STUDY
Case Series: Maraviroc and Pravastatin as a Therapeutic Option to treat Long Covid/Post-Acute Sequelae of Covid (PASC)
